Woman With Synchronous Breast and Rectal Cancers, HBV Flare

A 55-year-old woman develops triple-negative breast cancer, rectal adenocarcinoma, and HBV reactivation during pembrolizumab treatment. Medscape News UK

Read the full article on medscape.com